Evidence map›Paper›PMID 30463555›Full record

ArticleBMC urology2018

Ameliorative effects of rutin against cisplatin-induced reproductive toxicity in male rats.

Sarwat Jahan, Asma Munawar, Suhail Razak, Sara Anam, Qurat Ul Ain, Hizb Ullah, Tayyaba Afsar, Mahmoud Abulmeaty, Ali Almajwal

Open access · goldAbstract read
In one paragraph

Article in BMC urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Evaluation of the impact ofHistology and histopathology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Testicular toxicity of cisplatin in rats: ameliorative effect of lycopene and N-acetylcysteine.Environmental science and pollution research international · 2022
    Article
  12. Article
  13. Molecules (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sarwat JahanReproductive physiology laboratory, Department of animal sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Asma MunawarReproductive physiology laboratory, Department of animal sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Suhail RazakReproductive physiology laboratory, Department of animal sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan. ruhail12345@yahoo.com.
Sara AnamReproductive physiology laboratory, Department of animal sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Qurat Ul AinReproductive physiology laboratory, Department of animal sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Hizb UllahReproductive physiology laboratory, Department of animal sciences, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Tayyaba AfsarDepartment of Biochemistry, Faculty of Biological SciencesQuaid-i-Azam University, Islamabad, Pakistan.
Mahmoud AbulmeatyDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Ali AlmajwalDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.
Quaid-i-Azam University · PKKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCisplatin (CP) or cis-diammine dichloroplatinum (II) is a platinum based standard antineoplastic drug which is used against variety of solid tumors and neoplasms. The present study aimed to evaluate the shielding effects of rutin against CP induced testicular toxicity in rats.

methods28 male rats were divided into four groups. First group was given saline orally while second group received intra-peritoneal (i.p) injection of cisplatin (7 mg/kg) on day first and received saline for next 13 days. Third group received i.p injection of cisplatin at day one and treated with rutin (75 mg/kg) orally for next 13 days. Fourth group was treated with rutin orally for 13 days. Animals were sacrificed on 14th day and reproductive organs were analyzed for various parameters.

resultsCisplatin treatment resulted in a significant decrease in daily sperm production, decrease in head length and % DNA in head, reduction of epithelial cell height, tubular diameter, reduction of the number of spermatogonia, spermatocytes and spermatids, increase in the thiobarbituric acid reactive substances (TBARS) and oxidative stress in testicular tissues, and change of the intra-testicular testosterone concentrations. Rutin co-treatment resulted in reversing cisplatin effect on DNA damage, sperm count, histological and biochemical parameters.

conclusionThese results indicated that rutin co-treatment could ameliorate cisplatin-induced reproductive toxicity in male rats.

Indexed as

AnimalsAntineoplastic AgentsCisplatinDNA DamageMaleOxidative StressRandom AllocationRatsRats, Sprague-DawleyReproductionRutinSpermatozoaSperm MotilityTestisAntineoplastic AgentsCisplatinRutinAntioxidantsCisplatinComet assayHistologyRutinTestosterone

Identifiers

PMID30463555
PMCPMC6249881
OpenAlexW2901640189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.